Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05311176
Title A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON) (nextHERIZON)
Acronym nextHERIZON
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Imugene Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Southern Medical Day Care Centre Wollongong New South Wales Australia Details
The Queen Elizabeth Hospital Woodville South South Australia 5011 Australia Details
Kaohsiung Medical University Hospital Kaohsiung City Taiwan Details
National Cheng Kung University Hospital Tainan City Taiwan Details
National Taiwan University Hospital Taipei Taiwan Details
Taipei Veterans General Hospital Taipei Taiwan Details
Chang Gung Memorial Hospital, Linkou Taoyuan City Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field